A detailed history of Alliancebernstein L.P. transactions in Illumina, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 2,491,715 shares of ILMN stock, worth $324 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,491,715
Previous 2,658,630 6.28%
Holding current value
$324 Million
Previous $365 Million 28.76%
% of portfolio
0.09%
Previous 0.13%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$101.05 - $133.57 $16.9 Million - $22.3 Million
-166,915 Reduced 6.28%
2,491,715 $260 Million
Q1 2024

May 14, 2024

SELL
$127.73 - $147.2 $3.18 Million - $3.67 Million
-24,913 Reduced 0.93%
2,658,630 $365 Million
Q4 2023

Feb 14, 2024

SELL
$92.79 - $142.53 $34.8 Million - $53.4 Million
-374,744 Reduced 12.25%
2,683,543 $374 Million
Q3 2023

Nov 14, 2023

SELL
$128.91 - $192.44 $9.17 Million - $13.7 Million
-71,156 Reduced 2.27%
3,058,287 $420 Million
Q2 2023

Aug 15, 2023

SELL
$183.43 - $232.67 $123 Million - $156 Million
-671,878 Reduced 17.67%
3,129,443 $587 Million
Q1 2023

May 15, 2023

SELL
$193.75 - $232.55 $13.2 Million - $15.8 Million
-68,082 Reduced 1.76%
3,801,321 $884 Million
Q4 2022

Feb 14, 2023

BUY
$187.24 - $242.74 $430 Million - $557 Million
2,294,942 Added 145.76%
3,869,403 $782 Million
Q3 2022

Nov 15, 2022

BUY
$177.23 - $227.44 $119 Million - $153 Million
671,462 Added 74.36%
1,574,461 $300 Million
Q2 2022

Aug 15, 2022

SELL
$181.58 - $368.0 $35.8 Million - $72.6 Million
-197,329 Reduced 17.93%
902,999 $166 Million
Q1 2022

May 13, 2022

SELL
$303.87 - $423.8 $36.8 Million - $51.3 Million
-121,151 Reduced 9.92%
1,100,328 $384 Million
Q4 2021

Feb 14, 2022

BUY
$347.28 - $421.83 $26.3 Million - $31.9 Million
75,714 Added 6.61%
1,221,479 $465 Million
Q3 2021

Nov 10, 2021

BUY
$405.61 - $524.84 $70.5 Million - $91.2 Million
173,748 Added 17.87%
1,145,765 $465 Million
Q2 2021

Jul 30, 2021

SELL
$372.84 - $481.5 $21.5 Million - $27.7 Million
-57,571 Reduced 5.59%
972,017 $460 Million
Q1 2021

May 06, 2021

SELL
$361.28 - $504.76 $92.9 Million - $130 Million
-257,186 Reduced 19.99%
1,029,588 $395 Million
Q4 2020

Feb 08, 2021

SELL
$292.7 - $370.96 $26.3 Million - $33.3 Million
-89,791 Reduced 6.52%
1,286,774 $476 Million
Q3 2020

Nov 12, 2020

SELL
$268.51 - $400.74 $151 Million - $225 Million
-560,593 Reduced 28.94%
1,376,565 $425 Million
Q2 2020

Aug 13, 2020

BUY
$256.46 - $373.01 $24.3 Million - $35.3 Million
94,742 Added 5.14%
1,937,158 $717 Million
Q1 2020

May 14, 2020

SELL
$209.2 - $335.53 $8.18 Million - $13.1 Million
-39,091 Reduced 2.08%
1,842,416 $503 Million
Q4 2019

Feb 18, 2020

BUY
$288.29 - $335.49 $239 Million - $278 Million
829,865 Added 78.91%
1,881,507 $624 Million
Q3 2019

Nov 14, 2019

BUY
$266.84 - $378.23 $97.3 Million - $138 Million
364,804 Added 53.11%
1,051,642 $320 Million
Q2 2019

Aug 14, 2019

BUY
$300.59 - $368.15 $93.3 Million - $114 Million
310,519 Added 82.51%
686,838 $253 Million
Q1 2019

May 14, 2019

BUY
$272.57 - $321.18 $39 Million - $46 Million
143,243 Added 61.46%
376,319 $117 Million
Q4 2018

Feb 13, 2019

SELL
$272.46 - $366.54 $2.28 Million - $3.07 Million
-8,383 Reduced 3.47%
233,076 $69.9 Million
Q3 2018

Nov 08, 2018

BUY
$279.04 - $367.06 $1.95 Million - $2.57 Million
6,997 Added 2.98%
241,459 $88.6 Million
Q2 2018

Aug 13, 2018

SELL
$228.17 - $292.07 $37,419 - $47,899
-164 Reduced 0.07%
234,462 $65.5 Million
Q1 2018

May 14, 2018

SELL
$209.54 - $253.91 $5.07 Million - $6.14 Million
-24,172 Reduced 9.34%
234,626 $55.5 Million
Q4 2017

Feb 13, 2018

SELL
$202.23 - $230.03 $1.07 Million - $1.22 Million
-5,307 Reduced 2.01%
258,798 $56.5 Million
Q3 2017

Nov 13, 2017

BUY
$172.3 - $213.93 $45.5 Million - $56.5 Million
264,105
264,105 $52.6 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $20.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.